SB11
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SB11, covering 2024-12-30 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV [Phase 2]